Michael Parks | Vice President, Investor Relations |
Dr. Lishan Aklog | Chairman and CEO |
Dennis McGrath | Chief Financial Officer |
Kyle Mikson | Canaccord Genuity |
Ross Osborn | Cantor Fitzgerald |
Mike Matson | Needham & Co. |
Mark Massaro | BTIG |
Edward Woo | Ascendiant Capital |
Welcome to the Lucid Diagnostics Business Update and Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode. Later, we will conduct a question-and-answer session.
I would now like to turn the call over to your host, Michael Parks, Vice President, Investor Relations. Mr.